HYPERION DEFI, INC. Share-based Compensation Arrangement by Share-based Payment Award, Fair Value Assumptions, Expected Volatility Rate
HYPERION DEFI, INC. (HYPD) reported Share-based Compensation Arrangement by Share-based Payment Award, Fair Value Assumptions, Expected Volatility Rate of 121.00% for the 12-month period ending 2025-12-31, per its 10-K filed 2026-03-30.
Financial Statements › Notes › Compensation Related Costs › Share-Based Payment Arrangement, Disclosure › Share-Based Compensation Arrangement by Share-Based Payment Award, Fair Value Assumptions and Methodology
us-gaap:ShareBasedCompensationArrangementByShareBasedPaymentAwardFairValueAssumptionsExpectedVolatilityRate · last filed 2026-03-30
- HYPERION DEFI, INC. share-based compensation arrangement by share-based payment award, fair value assumptions, expected volatility rate for the quarter ending 2025-09-30 was 121.00%, a 39.08% increase year-over-year.
- HYPERION DEFI, INC. share-based compensation arrangement by share-based payment award, fair value assumptions, expected volatility rate for the quarter ending 2024-09-30 was 87.00%.
- HYPERION DEFI, INC. share-based compensation arrangement by share-based payment award, fair value assumptions, expected volatility rate for the quarter ending 2022-06-30 was 88.00%, a 5.38% decline year-over-year.
- HYPERION DEFI, INC. share-based compensation arrangement by share-based payment award, fair value assumptions, expected volatility rate for the quarter ending 2021-09-30 was 92.00%.
- HYPERION DEFI, INC. share-based compensation arrangement by share-based payment award, fair value assumptions, expected volatility rate for fiscal 2025 was 121.00%.
- HYPERION DEFI, INC. share-based compensation arrangement by share-based payment award, fair value assumptions, expected volatility rate for fiscal 2017 was 130.00%, a 0.76% decline from fiscal 2016.
- HYPERION DEFI, INC. share-based compensation arrangement by share-based payment award, fair value assumptions, expected volatility rate for fiscal 2016 was 131.00%.
| Period end | Share-based Compensation Arrangement by Share-based Payment Award, Fair Value Assumptions, Expected Volatility Rate 3 month | Share-based Compensation Arrangement by Share-based Payment Award, Fair Value Assumptions, Expected Volatility Rate 3 month as first filed | Share-based Compensation Arrangement by Share-based Payment Award, Fair Value Assumptions, Expected Volatility Rate 6 month | Share-based Compensation Arrangement by Share-based Payment Award, Fair Value Assumptions, Expected Volatility Rate 9 month | Share-based Compensation Arrangement by Share-based Payment Award, Fair Value Assumptions, Expected Volatility Rate 12 month |
|---|---|---|---|---|---|
| 2025-12-31 | 121.00% 10-K · filed 2026-03-30 | ||||
| 2025-09-30 | 121.00% 10-Q · filed 2025-11-14 | 121.00% 10-Q · filed 2025-11-14 | |||
| 2024-09-30 | 87.00% 10-Q · filed 2025-11-14 | ||||
| 2022-06-30 | 88.00% 10-Q · filed 2023-08-11 | ||||
| 2021-09-30 | 92.00% 10-Q · filed 2022-11-14 | ||||
| 2021-06-30 | 93.00% 10-Q · filed 2022-08-11 | ||||
| 2021-03-31 | 94.00% 10-Q · filed 2022-05-13 | 96.00% 10-Q · filed 2021-05-14 | |||
| 2020-06-30 | 99.00% 10-Q · filed 2021-08-12 | ||||
| 2020-03-31 | 101.00% 10-Q · filed 2021-05-14 | ||||
| 2019-09-30 | 134.00% 10-Q · filed 2020-11-12 | ||||
| 2019-06-30 | 139.00% 10-Q · filed 2020-08-14 | ||||
| 2019-03-31 | 139.00% 10-Q · filed 2020-05-14 | ||||
| 2018-09-30 | 139.00% 10-Q · filed 2020-05-14 | 141.00% 10-Q · filed 2018-11-13 | |||
| 2018-06-30 | 140.00% 10-Q · filed 2019-08-13 | 140.00% 10-Q · filed 2019-08-13 | |||
| 2018-03-31 | 0.00% 10-Q · filed 2019-05-14 | ||||
| 2017-12-31 | 130.00% 10-K · filed 2019-03-27 | ||||
| 2017-09-30 | 130.00% 10-Q · filed 2018-11-13 | 130.00% 10-Q · filed 2018-11-13 | |||
| 2016-12-31 | 131.00% 10-K · filed 2018-04-02 |
Similar stocks
| Stock Name | Country | Market Cap | PE Ratio |
|---|---|---|---|
| Rein Therapeutics, Inc. (RNTX) | United States | $0.063B | -1.76 |
| XBiotech Inc. (XBIT) | United States | $0.066B | -1.56 |
| Skye Bioscience, Inc. (SKYE) | United States | $0.061B | -0.48 |
| CalciMedica, Inc. (CALC) | United States | $0.061B | -1.42 |
| TALPHERA, INC. (TLPH) | United States | $0.060B | |
| Connect Biopharma Holdings Ltd (CNTB) | $0.069B | -2.17 | |
| Yarrow Bioscience, Inc. (YARW) | United States | $0.070B | |
| Boundless Bio, Inc. (BOLD) | United States | $0.059B | -0.88 |
| NOMAD POWER SOLUTIONS, INC. (NMAD) | United States | $0.058B | |
| PLIANT THERAPEUTICS, INC. (PLRX) | United States | $0.071B | -0.76 |